Alchemist Capital
General contacts
Investor type
VC / Debt fund
Founded
October, 2026
AUM
-
Location
New York, New York, United States
Investor profile last updated: 22 October, 2026
Profile
Alchemist Capital is a biotechnology investment firm based in New York City, founded by Andy Tran, who previously played a pivotal role in biotechnology investment platforms at Andreessen Horowitz and Matrix Capital. The firm is dedicated to identifying and backing next-generation biotechnology companies, focusing on those developing first-in-class or best-in-class medicines. Alchemist Capital is distinguished by its integration of deep fundamental research with a proprietary AI-native research and monitoring engine, which aims to industrialize and systematize the biotech research process for a more scalable investment approach.
Industry
Alchemist Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Biotechnology Investment Fund
|
Venture Capital (VC)
Debt fund
|
Biotechnology
AI
Life Sciences
|
Late Stage (Series C+)
|
North America
|
$0-1 m
|
$100 M
|
October 2026
|
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for Alchemist Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about Alchemist Capital
Is Alchemist Capital a venture capital or private equity firm?
Alchemist Capital is a venture capital firm that also operates as a debt fund. It backs companies at Late Stage (Series C+), writing tickets of $0-1 m.
Where is Alchemist Capital located?
Alchemist Capital is located in New York, New York, United States.
When was Alchemist Capital founded?
Alchemist Capital was founded in 2026.
What sectors and industries does Alchemist Capital invest in?
Alchemist Capital invests in companies and startups in Life Sciences, AI, Medical Devices, Healthcare Services, Biotechnology.
What is Alchemist Capital geographical focus of investments?
Alchemist Capital invests in companies and startups in North America.
At what stages of companies and startups does Alchemist Capital typically invest in?
Alchemist Capital invests in companies and startups at Late Stage (Series C+).
What is the usual amount of Alchemist Capital investment?
Alchemist Capital usually invests $0-1 m on average.
When was Alchemist Capital last fund created?
Alchemist Capital last fund was created/launched in 2026-10-13
What are the contacts of Alchemist Capital?
Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Alchemist Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access Alchemist Capital data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Alchemist Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the Alchemist Capital profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 22 October, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.